State of Wisconsin Investment Board’s Abeona Therapeutics ABEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-3,852
Closed -$98K 1983
2020
Q3
$98K Buy
+3,852
New +$243K ﹤0.01% 1937
2019
Q3
Sell
-1,720
Closed -$206K 1540
2019
Q2
$206K Buy
1,720
+36
+2% +$6.04K ﹤0.01% 1485
2019
Q1
$310K Buy
1,684
+388
+30% +$69.4K ﹤0.01% 1419
2018
Q4
$231K Buy
1,296
+536
+71% +$117K ﹤0.01% 1442
2018
Q3
$243K Hold
760
﹤0.01% 1483
2018
Q2
$304K Hold
760
﹤0.01% 1396
2018
Q1
$273K Hold
760
﹤0.01% 1374
2017
Q4
$301K Hold
760
﹤0.01% 1360
2017
Q3
$324K Hold
760
﹤0.01% 1363
2017
Q2
$122K Buy
+760
New +$104K ﹤0.01% 1435

Other funds holding ABEO

State of Wisconsin Investment Board's ABEO Position: Q4 2020 in Review

State of Wisconsin Investment Board sold out of Abeona Therapeutics (ABEO) in Q4 2020, closing a stake of 3,852 shares — an estimated $98K sold.

State of Wisconsin Investment Board first reported a position in ABEO in Q2 2017 and held it in 10 quarters. The position peaked at $324K in Q3 2017. 73 funds tracked by Wall St. Rank hold ABEO as of Q4 2020.

  • State of Wisconsin Investment Board reported no remaining Abeona Therapeutics position as of Q4 2020 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 3,852 Abeona Therapeutics shares in Q4 2020, an estimated $98K.
  • State of Wisconsin Investment Board first reported a position in Abeona Therapeutics in Q2 2017 and held it in 10 quarters.
  • State of Wisconsin Investment Board's Abeona Therapeutics position peaked at $324K in Q3 2017.
  • 73 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q4 2020.

Based on State of Wisconsin Investment Board's 13F filing for Q4 2020, filed 3 Feb 2021.